Business Wire

EURid Winning Registry of the Year Tops List of Big Developments in Q4 2017

Del

Q4 2017 gave way to 223 440 new .eu domain name registrations, which puts the .eu top-level domain (TLD) at 3 815 055 total domain names registered at the end of the quarter. When compared to Q3 2017, that measures an increase of 43 750 domain names registered, and when compared to Q4 2016, that measures an increase of 54 360 domain names registered.

Developments from the quarter include EURid’s continued support of Surfrider, successful .eu Web Awards Gala, release of the fall .eu Illustrated, introduction to EURid’s domain abuse prevention tool, hosting of a green discussion panel at the 2017 Internet Governance Forum, and winning the Registry of the Year Award at the 2017 CENTR Awards.

“Q4 2017 was a great quarter for us, particularly in seeing sustained growth not only in terms of registrations, but also in terms of registrar relations. Our registrar community grew by 8 members since Q3 and 30 members since the start of the year”, commented Giovanni Seppia, EURid’s External Relations Manager.

EURid works with 723 registrars who promote the .eu and .ею TLD to people all around the world. Winning the Registry of the Year Award shows EURid’s commitment towards their registrars, as they represent those who voted on the Award.

The top growth countries in the quarter when compared to Q3 2017 were Ireland (+16.7%), Iceland (+14.2%), and Liechtenstein (+11.1%).

Learn more about EURid’s developments in their Q4 2017 report and stay tuned for the 2017 annual report, which will be released in April.

About EURid

EURid is the non-profit organisation that operates the .eu and .ею TLDs, following a tender process and appointment by the European Commission. EURid works with over 700 accredited registrars and provides support in the 24 official EU languages. As part of its ongoing commitment to data security, EURid has been certified for the ISO27001 security standard since 2013. EURid is also registered by the EU Eco-Management and Audit Scheme (EMAS), which is an expression of its environmental commitment. More information at: http://www.eurid.eu.

Contact information

EURid
Christopher Nicastro, +32-(0)2-401-27-50
Communication Support Manager

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Asuragen to Launch the AmplideX® PCR/CE DMPK Kit and Present Growing Genetic Testing Portfolio at 2018 European Society of Human Genetics (ESHG) Conference22.5.2018 12:00Pressemelding

Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy to use products for complex testing in genetics and oncology, today announced the launch of the AmplideX® PCR/CE DMPK Kit* to simplify analysis of repeat expansions within the DMPK gene, which is implicated in myotonic dystrophy type I (DM1), also known as Steinert’s disease. DM1 is an inherited form of muscular dystrophy that affects the muscles as well as multiple other organ systems, and its severity is largely determined by the size of the CTG trinucleotide repeat expansion within the DMPK gene. These expansions commonly extend beyond a thousand CTG repeats and therefore have required the use of cumbersome Southern blot technology to estimate their size. “The AmplideX DMPK Kit represented a significant improvement over our existing process for analyzing large DMPK expansions,” said Doctor Sophie Rondeau, PharmD, PhD, and Professor Jean-Paul Bonnefont, MD, PhD, of the Necker-Enfants Malades Hospital in Par

Phil Brakewell Set to Lead WilsonHCG's Executive Search Efforts Across EMEA; Forbes Ranks WilsonHCG Among Best Executive Recruiting Firms22.5.2018 12:00Pressemelding

WilsonHCG, global leader and premium provider of innovative talent solutions, further expands its Executive Search division with the appointment of Director Phil Brakewell. Phil, who brings more than 14 years of talent acquisition leadership experience and most recently served as Head of Executive Search for ResourceBank, will be responsible for leading WilsonHCG’s efforts in the EMEA region. Prior to joining ResourceBank, Phil held consultant and resourcing leadership positions at Hitchenor Wakeford and The Caudwell Group – where he was responsible for developing the business internationally and drove innovative search solutions on behalf of a diverse range of clients. “WilsonHCG’s reputation speaks for itself,” said Phil. “WilsonHCG tailors its key service offerings – including Executive Search – to suit individual client needs, and I am thrilled to be part of such a dedicated, innovative team. The new Director position, covering EMEA, demonstrates our commitment to both Executive Se

Celgene to Present New and Updated Data across a Range of Blood Diseases at EHA 201822.5.2018 11:30Pressemelding

Celgene Corporation (NASDAQ:CELG) today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association (EHA) annual meeting in Stockholm, Sweden, from June 14-17, 2018. "We are proud to be sharing new and updated data around our innovative hematological therapies at EHA 2018, which further our understanding of blood cancers and other blood-related diseases and allow us to continue to have a major impact on the lives of patients," said Nadim Ahmed, President, Hematology & Oncology Franchise. "The data presented at EHA underscore the important role of immunomodulatory drugs at various stages of multiple myeloma, as well as illustrate our ongoing work in developing innovative treatment options, such as our erythroid maturation agent and CAR T cell therapies, for patients with life threatening blood disorders and cancers." At EHA this

New Research from Displaydata and Planet Retail RNG Estimates That Global Retailers Spent $104 Billion on Manually Changing Price Labels in 201722.5.2018 11:02Pressemelding

New research launched today by Displaydata and Planet Retail RNG reveals that inaccurate, inconsistent pricing – and a lack of digital technology in-store – is costing retailers in lost sales and consumer trust, as price-conscious shoppers seek out the best deal and better experiences online. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180522005419/en/ According to a new report from Displaydata and Planet Retail RNG, over two thirds of shoppers want technologies that enhance their experiences in stores. 33% want promotions sent direct to their mobile devices; 31% want Electronic Shelf Labels (ESLs) to show accurate, real-time prices, promotions, and detailed product information; and 27% want to be identified as a loyal customer. (Photo: Business Wire) The research report, Analogue to Automated: Retail in the Connected Age – which surveyed 5000 consumers and 1000 retailers – sought to understand what consumers want from ph

Now, officially Cool! Price f(x) named “Gartner® Cool Vendor in Digital Commerce”22.5.2018 10:01Pressemelding

Price f(x), a leader in Price Optimization & Management SaaS, has been named a “Cool Vendor in Digital Commerce” in the 2018 report by Gartner®, Inc.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180522005662/en/ Price f(x) is the pioneer of native Price Optimization & Management SaaS (“PO&M SaaS”) offering uniquely flexible, functionally broad and fast to implement solutions. In the report, Gartner® highlights Price f(x) as a true disruptor in this software segment through uncompromised customer-centric approach best reflected in the commercial offering of Pricing-as-a-Service (“PraaS™”). “We are devoted to simplicity, relevance and agility, but most importantly to commercial fairness. Our solution is designed, both technically and commercially, to quickly provide value to companies of any size, in any industry, in B2B, B2C as well as B2B2C. And offering all of that entirely free of implementation costs in our PraaS™ offe

Large-Scale Body Composition Study Reveals Link between Specific Fat Distributions and Metabolic Diseases22.5.2018 08:16Pressemelding

Specific patterns of fat distribution are linked to the presence of Coronary Heart Disease (CHD) and Type 2 Diabetes (T2D), according to a new study published in Obesity. 1 AMRA, the international leader in body composition analysis, today announced the results of a body composition study of over 6,000 subjects, stressing the need to measure and investigate several fat compartments in order to understand and develop treatments for multiple metabolic diseases. The new findings go far beyond what can be described by sex, age, lifestyle, BMI, or a single fat compartment, and have the potential to strongly impact how metabolic conditions will be prevented and managed in the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180522005616/en/ The Obesity study was co-authored in collaboration between AMRA, Pfizer, Westminster University, Linköping University, and UK Biobank. The 6,000 subjects analyzed are part of the UK Bioba